VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ISA 2022 | The multidisciplinary management of hATTR amyloidosis

Marcus Anthony Urey, MD, University of California, San Diego, CA, comments on the the multidisciplinary management of hereditary transthyretin-mediated (hATTR) amyloidosis, explaining that using a team comprising nephrologists, hematologists, cardiologists, and neurologists will help patients get comprehensive care and experience an improvement in the overall burden of their disease. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

Disclosures

Consultancy: Alnylam, Akcea, BridgeBio
Honoraria: Pfizer
Research support: Ionis

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter